Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (10): 987-997.doi: 10.19982/j.issn.1000-6621.20220321
• Guideline·Standard·Consensus • Previous Articles Next Articles
Tuberculosis Control Branch of Chinese Antituberculosis Association, Elderly Tuberculosis Control Branch of Chinese Antituberculosis Association(), Editorial Board of Chinese Journal of Antituberculosis()
Received:
2022-08-19
Online:
2022-10-10
Published:
2022-09-30
Contact:
Elderly Tuberculosis Control Branch of Chinese Antituberculosis Association,Editorial Board of Chinese Journal of Antituberculosis
E-mail:xueqiongwu@139.com
CLC Number:
Tuberculosis Control Branch of Chinese Antituberculosis Association, Elderly Tuberculosis Control Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for active screening of pulmonary tuberculosis in Chinese communities[J]. Chinese Journal of Antituberculosis, 2022, 44(10): 987-997. doi: 10.19982/j.issn.1000-6621.20220321
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220321
[1] | World Health Organization. Global tuberculosis report 2021, Geneva: World Health Organization, 2021. |
[2] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012, 34(8): 485-508. |
[3] | 中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02. |
[4] | 赵雁林, 陈明亭. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021. |
[5] | World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. Geneva: World Health Organization, 2021. |
[6] | World Health Organization. WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization, 2014. |
[7] |
Chen Y, Yang K, MarušićA, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Z Evid Fortbild Qual Gesundhwes, 2017, 127/128: 3-10. doi: 10.1016/j.zefq.2017.10.008.
doi: 10.1016/j.zefq.2017.10.008 URL |
[8] |
Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18): E839-E842. doi: 10.1503/cmaj.090449.
doi: 10.1503/cmaj.090449 URL |
[9] |
蒋朱明, 詹思延, 贾晓巍, 等. 制订/修订《临床诊疗指南》的基本方法及程序. 中华医学杂志, 2016, 96(4): 250-253. doi: 10.3760/cma.j.issn.0376-2491.2016.04.004.
doi: 10.3760/cma.j.issn.0376-2491.2016.04.004 |
[10] |
陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则(2022版). 中华医学杂志, 2022, 102(10): 697-703. doi: 10.3760/cma.j.cn112137-20211228-02911.
doi: 10.3760/cma.j.cn112137-20211228-02911 |
[11] | 李峻, 刘小秋, 李雪, 等. 肺结核可疑症状者的发生频度和地区分布研究. 中国防痨杂志, 2012, 34(9): 567-571. |
[12] | World Health Organization. WHO operational handbook on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. Geneva: World Health Organization, 2021. |
[13] |
Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med, 2011, 8(1): e1000391. doi: 10.1371/journal.pmed.1000391.
doi: 10.1371/journal.pmed.1000391 URL |
[14] |
Burke RM, Nliwasa M, Feasey HRA, et al. Community-based active case-finding interventions for tuberculosis: a systematic review. Lancet Public Health, 2021, 6(5): e283-e299. doi: 10.1016/S2468-2667(21)00033-5.
doi: 10.1016/S2468-2667(21)00033-5 |
[15] |
Zhao F, Zhang C, Yang C, et al. Comparison of yield and relative costs of different screening algorithms for tuberculosis in active case-finding: a cross-section study. BMC Infect Dis, 2021, 21(1): 813. doi: 10.1186/s12879-021-06486-w.
doi: 10.1186/s12879-021-06486-w pmid: 34388976 |
[16] |
Telisinghe L, Fielding KL, Malden JL, et al. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One, 2014, 9(1): e87262. doi: 10.1371/journal.pone.0087262.
doi: 10.1371/journal.pone.0087262 URL |
[17] |
Nguyen TBP, Nguyen TA, Luu BK, et al. A comparison of digital chest radiography and Xpert MTB/RIF in active case finding for tuberculosis. Int J Tuberc Lung Dis, 2020, 24(9): 934-940. doi: 10.5588/ijtld.19.0764.
doi: 10.5588/ijtld.19.0764 pmid: 33156761 |
[18] |
Triasih R, Robertson C, de Campo J, et al. An evaluation of chest X-ray in the context of community-based screening of child tuberculosis contacts. Int J Tuberc Lung Dis, 2015, 19(12): 1428-1434. doi: 10.5588/ijtld.15.0201.
doi: 10.5588/ijtld.15.0201 pmid: 26614182 |
[19] |
Andronikou S, Grier D, Minhas K. Reliability of chest radiograph interpretation for pulmonary tuberculosis in the screening of childhood TB contacts and migrant children in the UK. Clin Radiol, 2021, 76(2): 122-128. doi: 10.1016/j.crad.2020.08.035.
doi: 10.1016/j.crad.2020.08.035 pmid: 33010931 |
[20] |
Nijiati M, Zhang Z, Abulizi A, et al. Deep learning assistance for tuberculosis diagnosis with chest radiography in low-resource settings. J Xray Sci Technol, 2021, 29(5): 785-796. doi: 10.3233/XST-210894.
doi: 10.3233/XST-210894 |
[21] |
Yoon C, Chaisson LH, Patel SM, et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis. Int J Tuberc Lung Dis, 2017, 21(9): 1013-1019. doi: 10.5588/ijtld.17.0078.
doi: 10.5588/ijtld.17.0078 pmid: 28826451 |
[22] |
Shapiro AE, Hong T, Govere S, et al. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa. AIDS, 2018, 32(13): 1811-1820. doi: 10.1097/QAD.0000000000001902.
doi: 10.1097/QAD.0000000000001902 pmid: 29847333 |
[23] |
Velen K, Shingde RV, Ho J, et al. The effectiveness of contact investigation among contacts of tuberculosis patients: a systematic review and meta-analysis. Eur Respir J, 2021, 58(6): 2100266. doi: 10.1183/13993003.00266-2021.
doi: 10.1183/13993003.00266-2021 |
[24] |
张家泳, 丛守婧, 王涛, 等. 中国肺结核患者家庭密切接触者活动性肺结核检出情况的Meta分析. 中国防痨杂志, 2016, 38(10): 862-868. doi: 10.3969/j.issn.1000-6621.2016.10.015.
doi: 10.3969/j.issn.1000-6621.2016.10.015 |
[25] |
Cavany SM, Sumner T, Vynnycky E, et al. An evaluation of tuberculosis contact investigations against national standards. Thorax, 2017, 72(8): 736-745. doi: 10.1136/thoraxjnl-2016-209677.
doi: 10.1136/thoraxjnl-2016-209677 pmid: 28389598 |
[26] | 李婕. 肺结核患者家庭密切接触者筛查策略比较研究. 北京: 中国疾病预防控制中心, 2016. |
[27] |
Park SY, Han S, Kim YM, et al. Risk of active tuberculosis development in contacts exposed to infectious tuberculosis in congregate settings in Korea. Sci Rep, 2020, 10(1): 1306. doi: 10.1038/s41598-020-57697-1.
doi: 10.1038/s41598-020-57697-1 pmid: 31992740 |
[28] |
Lee MR, Ho CM, Lee CH, et al. Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan. Eur Respir J, 2017, 50(2): 1700851. doi: 10.1183/13993003.00851-2017.
doi: 10.1183/13993003.00851-2017 |
[29] |
Vega V, Rodríguez S, Van der Stuyft P, et al. Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections. Thorax, 2021, 76(5): 494-502. doi: 10.1136/thoraxjnl-2020-215449.
doi: 10.1136/thoraxjnl-2020-215449 pmid: 33547088 |
[30] |
Verver S, Warren RM, Beyers N, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med, 2005, 171(12): 1430-1435. doi: 10.1164/rccm.200409-1200OC.
doi: 10.1164/rccm.200409-1200OC URL |
[31] |
Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax, 2006, 61(2): 158-163. doi: 10.1136/thx.2005.045963.
doi: 10.1136/thx.2005.045963 pmid: 16254056 |
[32] |
成君, 赵飞, 夏愔愔, 等 既往结核病患者中肺结核患病状况及发现策略研究. 中国防痨杂志, 2015, 37(10): 1024-1029. doi: 10.3969/j.issn.1000-6621.2015.10.005.
doi: 10.3969/j.issn.1000-6621.2015.10.005 |
[33] |
Marx FM, Cohen T, Lombard C, et al. Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa. Int J Tuberc Lung Dis, 2019, 23(8): 891-899. doi: 10.5588/ijtld.18.0609.
doi: 10.5588/ijtld.18.0609 pmid: 31533878 |
[34] |
地尔木拉提·吐孙, 麦维兰江·阿不力米提, 刘振江, 等. 2011-2020年新疆喀什地区初治肺结核患者复发影响因素分析. 中国防痨杂志, 2021, 43(11): 1176-1182. doi: 10.3969/j.issn.1000-6621.2021.11.013.
doi: 10.3969/j.issn.1000-6621.2021.11.013 |
[35] |
彭红, 虞浩, 姜洁, 等. 江苏省初治结核病复发流行病学特征及影响因素. 江苏预防医学, 2019, 30(4): 355-359. doi: 10.13668/j.issn.1006-9070.2019.04.001.
doi: 10.13668/j.issn.1006-9070.2019.04.001 |
[36] |
张灿有, 陈彬, 叶建君, 等. 中国重点人群肺结核患病与发病调查分析. 中国防痨杂志, 2021, 43(12): 1260-1268. doi: 10.3969/j.issn.1000-6621.2021.12.006.
doi: 10.3969/j.issn.1000-6621.2021.12.006 |
[37] |
Martinez L, Cords O, Horsburgh CR, et al. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet, 2020, 395(10228): 973-984. doi: 10.1016/S0140-6736(20)30166-5.
doi: S0140-6736(20)30166-5 pmid: 32199484 |
[38] | 李乐, 周子豪, 吴群红, 等. HIV感染者/AIDS患者中结核病检出率的meta分析. 职业与健康, 2019, 35(24): 3437-3441. |
[39] |
杨蕊, 邱玉冰, 苏玮玮, 等. 云南省TB/HIV双重感染患者抗结核治疗死亡危险因素生存分析. 中华疾病控制杂志, 2016, 20(12): 1212-1215, 1226. doi: 10.16462/j.cnki.zhjbkz.2016.12.007.
doi: 10.16462/j.cnki.zhjbkz.2016.12.007 |
[40] |
何纳. 中国艾滋病流行病学研究新进展. 中华疾病控制杂志, 2021, 25(12): 1365-1368, 1480. doi: 10.16462/j.cnki.zhjbkz.2021.12.001.
doi: 10.16462/j.cnki.zhjbkz.2021.12.001 |
[41] |
Hamada Y, Lujan J, Schenkel K, et al. Sensitivity and specificity of WHO’s recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. Lancet HIV, 2018, 5(9): e515-e523. doi: 10.1016/S2352-3018(18)30137-1.
doi: 10.1016/S2352-3018(18)30137-1 |
[42] |
Dhana A, Hamada Y, Kengne AP, et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis, 2022, 22(4): 507-518. doi: 10.1016/S1473-3099(21)00387-X.
doi: 10.1016/S1473-3099(21)00387-X URL |
[43] | 国家统计局, 国务院第七次全国人口普查领导小组办公室. 第七次全国人口普查公报(第五号)--人口年龄构成情况[EB/OL]. [2022-04-30]. http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818824.html. |
[44] |
Donald PR, Marais BJ, Barry CE 3rd. Age and the epidemiology and pathogenesis of tuberculosis. Lancet, 2010, 375(9729): 1852-1854. doi: 10.1016/S0140-6736(10)60580-6.
doi: 10.1016/S0140-6736(10)60580-6 pmid: 20488519 |
[45] |
Pratt RH, Winston CA, Kammerer JS, et al. Tuberculosis in older adults in the United States, 1993-2008. J Am Geriatr Soc, 2011, 59(5): 851-857. doi: 10.1111/j.1532-5415.2011.03369.x.
doi: 10.1111/j.1532-5415.2011.03369.x. URL |
[46] |
Rajagopalan S. Tuberculosis in Older Adults. Clin Geriatr Med, 2016, 32(3): 479-491. doi: 10.1016/j.cger.2016.02.006.
doi: 10.1016/j.cger.2016.02.006 pmid: 27394018 |
[47] |
Cheng J, Sun YN, Zhang CY, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty, 2020, 9(1): 13. doi: 10.1186/s40249-019-0614-9.
doi: 10.1186/s40249-019-0614-9 pmid: 32005290 |
[48] |
王炜, 郝晓刚, 祝平. 浙江省衢州市农村老年人大规模主动筛查发现的肺结核病例特征分析. 疾病监测, 2021, 36(12): 1308-1311. doi: 10.3784/jbjc.202101270049.
doi: 10.3784/jbjc.202101270049 |
[49] |
张慧, 成君, 于艳玲, 等. 基于社区的重点人群肺结核主动发现干预效果评价:多中心前瞻性队列研究. 中国防痨杂志, 2021, 43(12): 1248-1259. doi: 10.3969/j.issn.1000-6621.2021.12.005.
doi: 10.3969/j.issn.1000-6621.2021.12.005 |
[50] | 张灿有, 王黎霞, 张慧, 等. 不同发现策略应用于老年肺结核患者发现的成本效果研究. 中国防痨杂志, 2013, 35(10): 793-798. |
[51] | Stead WW. Tuberculosis among elderly persons, as observed among nursing home residents. Int J Tuberc Lung Dis, 1998, 2(9 Suppl 1): S64-S70. |
[52] |
Cheng J, Yu Y, Ma Q, et al. Prevalence, Incidence, and Characteristics of Tuberculosis Among Known Diabetes Patients-A Prospective Cohort Study in 10 Sites, 2013-2015. China CDC Weekly, 2022, 4(3): 41-46. doi: 10.46234/ccdcw2022.004.
doi: 10.46234/ccdcw2022.004 URL |
[53] |
Lin Y, Innes A, Xu L, et al. Screening of patients with diabetes mellitus for tuberculosis in community health settings in China. Trop Med Int Health, 2015, 20(8): 1073-1080. doi: 10.1111/tmi.12519.
doi: 10.1111/tmi.12519 pmid: 25877338 |
[54] |
Berkowitz N, Okorie A, Goliath R, et al. The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting. Diabetes Res Clin Pract, 2018, 138: 16-25. doi: 10.1016/j.diabres.2018.01.018.
doi: 10.1016/j.diabres.2018.01.018 URL |
[55] |
Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health, 2010, 15(11): 1300-1314. doi: 10.1111/j.1365-3156.2010.02632.x.
doi: 10.1111/j.1365-3156.2010.02632.x pmid: 20958887 |
[56] |
Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide Screening for Tuberculosis in a High-Prevalence Setting. N Engl J Med, 2019, 381(14): 1347-1357. doi: 10.1056/NEJMoa1902129.
doi: 10.1056/NEJMoa1902129 URL |
[57] |
Houben RMGJ, Menzies NA, Sumner T, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health, 2016, 4(11): e806-e815. doi: 10.1016/S2214-109X(16)30199-1.
doi: 10.1016/S2214-109X(16)30199-1 |
[58] |
Van’t Hoog A, Viney K, Biermann O, et al. Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status. Cochrane Database Syst Rev, 2022, 3(3): CD010890. doi: 10.1002/14651858.CD010890.pub2.
doi: 10.1002/14651858.CD010890.pub2 |
[1] | National Clinical Research Centre for Infectious Disease/The Third People’s Hospital of Shenzhen, Peking University Shenzhen Hospital, Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Shenzhen Key Laboratory of Inflammatory and Immune Diseases. Expert consensus on diagnosis and treatment of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 869-879. |
[2] | Wang Yuxiang, Chen Qiuqi, Yu Xinxin, Zhan Senlin, Zhang Peize, Deng Guofang. 3HP regimen in the treatment of rheumatic diseases complicated with Mycobacterium tuberculosis latent infection:a prospective study [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 906-910. |
[3] | Xie Jingyi, Zou Ruifeng, Chen Yulan, Chen Yong, Liu Dongzhou, Hong Xiaoping. Analysis of clinical features and peripheral lymphocyte subsets of systemic lupus erythematosus patients complicated with tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 911-916. |
[4] | Cheng Xiao, Chen Zhe, Jiao Xuefeng, Yang Nan, Diao Sha, Ni Xiaofeng, Liu Zheng, He Siyi, Zeng Linan, Wan Chaomin, Kang Deying, Wu Bin, Ying Binwu, Zhang Hui, Zhao Rongsheng, Zhang Lingli. Efficacy and safety of recombinant Mycobacterium tuberculosis fusion proteins (EC) for the diagnosis of Mycobacterium tuberculosis infection: A system review [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 917-926. |
[5] | Wu Wenqi, Zhong Jianqiu, He Juan, Deng Guofang, Wang Qingwen. The research progress of the reactivation of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 954-959. |
[6] | Dong Xiaowei, Guo Huixin, Zhang Chenchen, Wang Jiawen, He Junlei, Li Guanhai, Li Jianwei, Wen Wenpei. Application value of two-step detection of Mycobacterium tuberculosis infection screening in schools [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 802-807. |
[7] | Li Yinhong, Liu Fanglin, Lu Zhenhui, Jiang Xin. Study on the mechanism of Oridonin against pathological damage of tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 849-854. |
[8] | XIA Hui, ZHENG Yang, SONG Yuan-yuan. Interpretation of the Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex issued by World Health Organization [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 641-645. |
[9] | LIU Hai-ting, LI Dong-shuo, ZHANG Lei, WANG Ning, WANG Bin, DING Yang-ming, YAO Rong, LU Yu. A preliminary study on the synergy and mechanism of pyrifazimine and bedaquiline [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 646-653. |
[10] | DAI Xiao-wei, WANG Nen-han, CHEN Shuang-shuang, YANG Xin-yu, TIAN Li-li, CHEN Hong, ZHANG Hong-tai, LI Chuan-you. Assessing next-generation sequencing for Mycobacterium tuberculosis diagnosis in clinical sputum samples [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 669-679. |
[11] | JIA Hong-yan, DONG Jing, ZHANG Zong-de, PAN Li-ping. Progress and clinical application of immunological detection technology for Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 720-726. |
[12] | The Joint Tuberculosis Professional Branch of Chinese Antituberculosis Association, The Western China Bone Tuberculosis Union, The North China Union of Bone Tuberculosis. Expert consensus on the diagnosis and treatment of Brucella spondylitis [J]. Chinese Journal of Antituberculosis, 2022, 44(6): 531-538. |
[13] | AN Hui-ru, WU Xue-qiong. Interpretation of immunoadjuvant therapy in Expert consensus on immune function assessment and immunotherapy in patients with active tuberculosis (2021 Edition) [J]. Chinese Journal of Antituberculosis, 2022, 44(6): 539-543. |
[14] | CHEN Zhi, LIANG Jian-qin. Expert consensus on nutritional assessment and nutritional support treatment for patients with severe tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 421-432. |
[15] | HE Yi-jun, CAO Xue-fang, GAO Lei. Interpretation of the Procedure of tuberculin skin test-interferon-gamma release assay two-step testing [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 438-441. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||